Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro.
about
Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum.Susceptibility Testing of Medically Important Parasites.Characterization of Host Cell Mutants Significantly Resistant to Cryptosporidium parvum Infection.Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs.The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases.
P2860
Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@ast
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@en
type
label
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@ast
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@en
prefLabel
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@ast
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@en
P2860
P356
P1476
Quantitative RT-PCR assay for ...... yptosporidium parvum in vitro.
@en
P2093
P2860
P356
10.3389/FMICB.2015.00991
P577
2015-09-22T00:00:00Z